144 related articles for article (PubMed ID: 613561)
1. [Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
Stumpe KO; Kolloch RE; Redlich B; Vetter H; Krück F
Verh Dtsch Ges Kreislaufforsch; 1977; 43():167-76. PubMed ID: 613561
[No Abstract] [Full Text] [Related]
2. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
Laragh JH; Case DB; Wallace JM; Keim H
Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic and therapeutic significance of antagonists of the renin-angiotensin system (author's transl)].
Stumpe KO; Overlack A; Krück F
Herz; 1978 Oct; 3(5):305-12. PubMed ID: 721057
[No Abstract] [Full Text] [Related]
4. Editorial: Mechanisms in hypertension.
Lancet; 1975 Sep; 2(7932):445. PubMed ID: 51247
[No Abstract] [Full Text] [Related]
5. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
Brunner HR; Gavras H
Schweiz Med Wochenschr; 1976 Dec; 106(50):1791-8. PubMed ID: 1013701
[TBL] [Abstract][Full Text] [Related]
6. [Renin-angiotensin system inhibitors - biochemical and clinical aspects].
Kuska J; Germakowska-Kowalik T; Pluta S
Postepy Hig Med Dosw; 1982; 35(4):395-411. PubMed ID: 6183653
[No Abstract] [Full Text] [Related]
7. [Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension].
Stumpe KO; Kolloch RE; Overlack A
Med Welt; 1977 Oct; 28(41):1645-9. PubMed ID: 927124
[No Abstract] [Full Text] [Related]
8. [Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension].
Novikova LS; Arabidze GG
Ter Arkh; 1979; 51(5):99-108. PubMed ID: 222004
[No Abstract] [Full Text] [Related]
9. Saralasin and SQ 20881 : their effects on central nervous system norepinephrine.
Martínez Seeber A; Fernández BE; Domínguez AE; Vidal NA
Arch Int Physiol Biochim; 1978 Feb; 86(1):175-8. PubMed ID: 80175
[TBL] [Abstract][Full Text] [Related]
10. [Various inhbitors of the renin-angiotensin system and their clinical use].
Bar-Andziak E
Pol Arch Med Wewn; 1979 Jan; 61(1):69-74. PubMed ID: 370806
[No Abstract] [Full Text] [Related]
11. Intrarenal effects of the renin-angiotensin system.
Ploth DW; Navar LG
Fed Proc; 1979 Aug; 38(9):2280-5. PubMed ID: 456614
[No Abstract] [Full Text] [Related]
12. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
Hollenberg NK; Williams GH
Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
[No Abstract] [Full Text] [Related]
13. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
Case DB; Wallace JM; Laragh JH
Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598
[No Abstract] [Full Text] [Related]
14. Angiotensin blockade in hypertension.
Streeten DH; Anderson GH
Ann Intern Med; 1977 Mar; 86(3):353-4. PubMed ID: 842997
[No Abstract] [Full Text] [Related]
15. Clinical implications of renin in the hypertensive patient.
Brunner HR; Gavras H
JAMA; 1975 Sep; 233(10):1091-3. PubMed ID: 1174160
[No Abstract] [Full Text] [Related]
16. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
[TBL] [Abstract][Full Text] [Related]
17. The effects of angiotensin II blockade in conscious sodium-depleted dogs.
Stephens GA; Davis JO; Freeman RH; Watkins BE; Khosla MC
Endocrinology; 1977 Aug; 101(2):378-8. PubMed ID: 885110
[No Abstract] [Full Text] [Related]
18. Stimulating effects of angiotensin I, angiotensin II and des-Asp1-angiotensin II on steroid production in vitro and its inhibition by Sar1-Ala8-angiotensin II.
Hepp R; Grillet C; Peytremann A; Vallotton MB
Prog Biochem Pharmacol; 1976; 12():41-8. PubMed ID: 1019169
[TBL] [Abstract][Full Text] [Related]
19. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
Atlas SA; Niarchos AP; Case DB
Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
